Randi Eichenbaum: BRCA2, Access to Care, and the birth of MOTA

Episode summary

Randi Eichenbaum was 19 when her mother died of ovarian cancer. Somewhere in those years she absorbed a quiet belief: this is going to happen to me too. Years later, a new OB-GYN recommended genetic testing based on her family history. The BRCA2 result came by phone from a third-party lab while she was at work, followed by an emailed PDF that no one walked her through. She put it in a drawer, literally and figuratively, and went back to work. What followed was a series of turning points. She became a mother and experienced acute postpartum anxiety. She had a prophylactic hysterectomy and oophorectomy three to four months after an emergency C-section. Then, while her preventive mastectomy was delayed, a routine MRI found stage 1 breast cancer.

At almost every turn, someone in Randi's personal life opened a door. Her mother's best friend, a longtime UCSF nurse, urged her to see a genetic counselor. Her sister-in-law, a breast cancer survivor, insisted she see Dr. Anne Peled. Randi and Sara explore the tension Randi names directly: feeling deeply lucky, and also a little bit pissed that this kind of care is the exception rather than the norm. That tension became MOTA, a digital companion for people with hereditary cancer risk, starting with BRCA1 and BRCA2 carriers. Together they talk about why a provider's experience and steadiness matter emotionally as well as medically, why surgical menopause carries so much fear, and why there is no real "other side" of carrying a genetic mutation.

We cover

• Growing up with a parent's ovarian cancer diagnosis and the internalized belief that "this is going to happen to me"

• Dissociating and building a career as a way of moving forward after loss

• Receiving a BRCA2 result by phone from a third-party lab with no one to walk her through it

• Emotional compartmentalization: putting a result "in a drawer" until life makes it impossible to ignore

• How approaching 40, the age her mother was diagnosed, and becoming a mother brought the urgency back

• Postpartum anxiety, grief for her mother, and choosing a hysterectomy and oophorectomy months after giving birth

• The relief of partnering with a genetic counselor and having an actual plan

• A stage 1 breast cancer diagnosis found on a routine MRI while preventive surgery was delayed

• The surgeon whose first words were "I'm sorry this is happening to you, but it's going to be okay"

• How access to excellent care often travels through informal networks, luck, and privilege

• Why a provider's familiarity with hereditary cancer risk affects how safe a patient feels, and which options get pushed

• Fear and misinformation around HRT and surgical menopause

• How MOTA works: a personalized roadmap based on NCCN guidelines, planning tools, a directory of providers experienced in hereditary cancer care, reminders, and mental health referrals

• The wounded healer: turning one of the hardest chapters of life into something for the community

• Why carrying a genetic mutation is lifelong, and what it means to trade one mental load for another

Highlights & takeaways

• "I'm sorry this is happening to you, but it's going to be okay." Randi recalls the first words her breast surgeon said to her, and the moment that became the foundation of MOTA.

• "There is this tension of feeling very lucky, but also a little bit pissed." Gratitude for good care and anger that it isn't the norm can live side by side.

• Getting a result is not the same as being supported to understand it. Randi had a phone call and a PDF. What she needed was a person to help her build a plan.

• A provider's comfort with hereditary cancer risk shapes the patient's experience. When carriers are an outlier on a caseload, fear can enter the room and push people toward the most cautious options without room for the rest of their lives.

• "We never want to explain ourselves." Working with a doctor or therapist who doesn't understand this position can feel isolating, even after years of therapy.

• "I've traded in one mental load for another." Finishing a surgery doesn't mean you are done. Carrying hereditary risk is a lifelong experience with new chapters.

Content note

This episode includes discussion of a parent's death from ovarian cancer during adolescence, a breast cancer diagnosis, postpartum anxiety, an emergency C-section, prophylactic hysterectomy and oophorectomy in the postpartum period, surgical menopause, fear of dying, and gaps in medical care.

Resources mentioned

• MOTA: A free digital companion for people with hereditary cancer risk, starting with women who carry a BRCA1 or BRCA2 mutation. Offers a personalized roadmap based on NCCN guidelines, planning tools, a provider directory, and mental health referrals. mota.care | Instagram @mota.care

• Randi Eichenbaum: Share a provider you recommend or feedback on what you wish you'd had: randi@mota.care

• Dr. Anne Peled: Breast surgeon in San Francisco, mentioned by Randi and by a previous Walking the Genetic Line guest, Violet Page

• Rachel Frankenthal, PA: Menopause specialist at UCLA Health and member of MOTA's advisory team

• UCSF genetic counseling: Where Randi met with a genetic counselor to build her plan

• NCCN Guidelines: The clinical guidelines MOTA's roadmaps are based on

• The Breasties: Online community and app for people affected by breast and reproductive cancers

Connect

If this conversation resonated, follow Walking the Genetic Line, rate and review the show, and share this episode with someone who is holding a result they haven't known what to do with.

Connect with Sara Champie, LCSW at sarachampielcsw.com and on Instagram @SaraChampieLCSW.

Let's walk this line, together.